Dudum Andrew 4

What Happened

• Andrew Dudum, CEO of Hims & Hers Health, Inc. (HIMS), was granted 413,844 restricted stock units (RSUs) on 2026-03-11. The RSUs were recorded at $0.00 (derivative award); no cash purchase occurred. Each RSU represents a contingent right to one share of Class A common stock upon vesting.

Key Details

• Transaction date: 2026-03-11; Form 4 filed: 2026-03-13 (filed within the standard 2-business-day reporting window).
• Grant: 413,844 RSUs; acquisition price: $0.00 (derivative award).
• Vesting: Service-based over 4 years in substantially equal quarterly installments on March 15, June 15, September 15 and December 15; first vesting date is June 15, 2026. (Footnotes: F1 and F2)
• Shares owned after transaction: Not specified in the provided filing.
• Transaction code: A (award/grant). This is a grant of contingent equity, not a market purchase or sale.

Context

• RSUs are a form of compensation that convert to actual shares only as they vest; they do not represent immediately tradable shares. This grant increases potential future share issuance as Dudum’s RSUs vest over time.
• Because this is an award (not a purchase or sale), it should be viewed as compensation-related rather than an immediate signal of buying or selling intent.